BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32251357)

  • 1. Low-dose 17α-ethinyl estradiol (EE) exposure exacerbates lupus renal disease and modulates immune responses to TLR7/9 agonists in genetically autoimmune-prone mice.
    Edwards MR; Dai R; Heid B; Cowan C; Werre SR; Cecere T; Ahmed SA
    Sci Rep; 2020 Mar; 10(1):5210. PubMed ID: 32251357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 7 agonist imiquimod prevents the progression of SLE in MRL/lpr mice via inhibiting the differentiation of T follicular helper cells.
    Duan X; Shen C; Zhang X; Wu L; Chen J; Ma B; Wang Q; Sun P; Lan Y; Su C
    Int Immunopharmacol; 2020 Mar; 80():106239. PubMed ID: 32007709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of toll-like receptor-7 exacerbates lupus nephritis by modulating regulatory T cells.
    Gong L; Wang Y; Zhou L; Bai X; Wu S; Zhu F; Zhu YF
    Am J Nephrol; 2014; 40(4):325-44. PubMed ID: 25341693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor-7 modulates immune complex glomerulonephritis.
    Pawar RD; Patole PS; Zecher D; Segerer S; Kretzler M; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2006 Jan; 17(1):141-9. PubMed ID: 16280469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
    Anders HJ; Vielhauer V; Eis V; Linde Y; Kretzler M; Perez de Lema G; Strutz F; Bauer S; Rutz M; Wagner H; Gröne HJ; Schlöndorff D
    FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia.
    Butchi NB; Du M; Peterson KE
    Glia; 2010 Apr; 58(6):650-64. PubMed ID: 19998480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17β-Estradiol and 17α-Ethinyl Estradiol Exhibit Immunologic and Epigenetic Regulatory Effects in NZB/WF1 Female Mice.
    Dai R; Edwards MR; Heid B; Ahmed SA
    Endocrinology; 2019 Jan; 160(1):101-118. PubMed ID: 30418530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.
    Santiago-Raber ML; Dunand-Sauthier I; Wu T; Li QZ; Uematsu S; Akira S; Reith W; Mohan C; Kotzin BL; Izui S
    J Autoimmun; 2010 Jun; 34(4):339-48. PubMed ID: 19944565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent Fasting Aggravates Lupus Nephritis through Increasing Survival and Autophagy of Antibody Secreting Cells in MRL/lpr Mice.
    Hong SM; Lee J; Jang SG; Song Y; Kim M; Lee J; Cho ML; Kwok SK; Park SH
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/
    Zhang LY; Li H; Wu YW; Cheng L; Yan YX; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F769-F777. PubMed ID: 28100505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.
    Elliott MK; Jarmi T; Ruiz P; Xu Y; Holers VM; Gilkeson GS
    Kidney Int; 2004 Jan; 65(1):129-38. PubMed ID: 14675043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 4, Toll-like receptor 7 and Toll-like receptor 9 agonists enhance immune responses against blood-stage Plasmodium chabaudi infection in BALB/c mice.
    Gao W; Sun X; Li D; Sun L; He Y; Wei H; Jin F; Cao Y
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107096. PubMed ID: 33091818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice.
    Zavala F; Masson A; Hadaya K; Ezine S; Schneider E; Babin O; Bach JF
    J Immunol; 1999 Nov; 163(9):5125-32. PubMed ID: 10528219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease.
    Pérez de Lema G; Lucio-Cazaña FJ; Molina A; Luckow B; Schmid H; de Wit C; Moreno-Manzano V; Banas B; Mampaso F; Schlöndorff D
    Kidney Int; 2004 Sep; 66(3):1018-28. PubMed ID: 15327395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice.
    Shi Y; Yao W; Sun L; Li G; Liu H; Ding P; Hu W; Xu H
    BMC Nephrol; 2019 Nov; 20(1):424. PubMed ID: 31752725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coactivation of Toll-like receptor-3 and -7 in immune complex glomerulonephritis.
    Patole PS; Pawar RD; Lichtnekert J; Lech M; Kulkarni OP; Ramanjaneyulu A; Segerer S; Anders HJ
    J Autoimmun; 2007 Aug; 29(1):52-9. PubMed ID: 17544622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus.
    Pawar RD; Ramanjaneyulu A; Kulkarni OP; Lech M; Segerer S; Anders HJ
    J Am Soc Nephrol; 2007 Jun; 18(6):1721-31. PubMed ID: 17460144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.
    Wu Y; He S; Bai B; Zhang L; Xue L; Lin Z; Yang X; Zhu F; He P; Tang W; Zuo J
    Cell Mol Immunol; 2016 May; 13(3):379-90. PubMed ID: 25942599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptidylarginine Deiminase 4 Promotes the Renal Infiltration of Neutrophils and Exacerbates the TLR7 Agonist-Induced Lupus Mice.
    Hanata N; Shoda H; Hatano H; Nagafuchi Y; Komai T; Okamura T; Suzuki A; Gunarta IK; Yoshioka K; Yamamoto K; Fujio K
    Front Immunol; 2020; 11():1095. PubMed ID: 32655553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.